<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM/HYPOTHESIS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increases the risk not only of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> but also of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The question remains whether <z:mp ids='MP_0002055'>diabetes</z:mp> increases the risk of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> by diabetic vasculopathy or whether <z:mp ids='MP_0002055'>diabetes</z:mp> influences directly the development of Alzheimer neuropathology </plain></SENT>
<SENT sid="2" pm="."><plain>In vivo, hippocampal and amygdalar <z:mpath ids='MPATH_127'>atrophy</z:mpath> on brain MRI are good, early markers of the degree of Alzheimer neuropathology </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the association between <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and the degree of hippocampal and amygdalar <z:mpath ids='MPATH_127'>atrophy</z:mpath> on magnetic resonance imaging (MRI) accounting for vascular pathology </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Data was obtained in a population-based study of elderly subjects without <z:hpo ids='HP_0000726'>dementia</z:hpo> between 60 to 90 years of age </plain></SENT>
<SENT sid="5" pm="."><plain>The presence of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and, in non-diabetic subjects, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> was assessed for 506 participants in whom hippocampal and amygdalar volumes on MRI were measured </plain></SENT>
<SENT sid="6" pm="."><plain>We assessed the degree of vascular morbidity by rating carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and brain white matter lesions and <z:mpath ids='MPATH_124'>infarcts</z:mpath> on MRI </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Subjects with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> had more hippocampal and amygdalar <z:mpath ids='MPATH_127'>atrophy</z:mpath> on MRI compared to subjects without <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, increasing <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> was associated with more amygdalar <z:mpath ids='MPATH_127'>atrophy</z:mpath> on MRI </plain></SENT>
<SENT sid="9" pm="."><plain>The associations were not due to vascular morbidity being more pronounced in persons with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS/INTERPRETATION: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is associated with hippocampal and amygdalar <z:mpath ids='MPATH_127'>atrophy</z:mpath>, regardless of vascular pathology </plain></SENT>
<SENT sid="11" pm="."><plain>This could suggest that Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> directly influences the development of Alzheimer neuropathology </plain></SENT>
</text></document>